Avior Bio Competitors and Similar CompaniesClear all
Livzon Pharmaceutical Group's competitors and similar companies include CSL Behring and Biogen.
 Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ||
Founding Date | Founding Date 1985 | Founding Date 1904 | Founding Date 1978 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 9,067 | Employees 7,5692% decrease | Employees 7,605 |
Valuation ($) | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) 26.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit ¥7.8b (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) |
Net income | Net income ¥2.4b (FY, 2025) | Net income N/A | Net income $1.3b (FY, 2025) |
Operating ⚠ | |||
Trademark Applications | Trademark Applications 3 (Sep, 2023) | Trademark Applications 1 (Dec, 2020) | Trademark Applications N/A |
Trademarks | Trademarks 45 (Sep, 2023) | Trademarks 4 (Dec, 2020) | Trademarks N/A |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company